Open questions of the pandemic, part 1
Kaiser discusses some open questions of the Covid-19 pandemic
Health
99.4% art, 0.6% data
Kaiser looks behind the CDC's "nowcast" of Omicron, and finds nothing.
Further adventures of case-counting windows
Kaiser discusses several observations from the Israel booster study.
Primer on Regression Adjustments 1
Kaiser starts a series of posts about regression adjustments.
Probabilities of Covid-19
Kaiser looks at how probabilities lie behind the science of vaccines.
Blood clots: is there a there
Kaiser looks at the controversy over blood clots and the Astrazeneca vaccine.